Monday, April 29, 2019

ARDS Phenotyping

ARDS Phenotyping       ( click on link for Lecture)

There isa clinical need to identify biomarkers that are associatedwith treatment response, independent of group membership. Therefore, consensus on biological sampling time points, biological dimension measured, and a standard minimum set of consensus biomarkers is required. The biological sampling should aim to refect the insults to the alveolar capillary membrane (ACM) (exudative phase), deposition of provisional matrix with proliferation of airway progenitor cells (proliferative phase), or interstitial and intra-alveolar fbrosis (fbrotic phase) of ARDS. Tis minimum set of markers could then be used to delineate discriminant markers of ARDS sub-phenotypes that provide prognostic enrichment with either a greater probability of therapeutically valid similarities or a greater likelihood of treatment response.

No comments:

Post a Comment

Featured Post

Fourth Universal Definition of Myocardial Infarction

The following are key points to remember from this Expert Consensus Document on the Fourth Universal Definition of Myocardial Infarction (M...